Concepedia
Statistics
Publications
32
Citations
3K
H-Index
22
Active since
1985
Affiliations
Pfizer (United States)(Current)
Lundbeck (United States)
Lundbeck (Denmark)
The University of Texas at Austin
GlaxoSmithKline (United Kingdom)
Stevin H. Zorn is an author at Pfizer (United States) specializing in medicine, pharmacology, and neuropharmacology.
Top concepts
MedicinePharmacologyNeuropharmacologyNeuroscienceDrug DiscoveryPharmacotherapySocial SciencesPsychopharmacologyMolecular PharmacologyPsychiatry
Publications per year
1985–2023
Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor
Masaaki Iwata, Kristie T. Ota, Xiaoyuan Li et al. · Biological Psychiatry · 2015 · 380 citations
Inflammation, Purinergic Type 2X7, Stress Psychology +12
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 320 citations
Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile
Anne W. Schmidt, Lorraine A. Lebel, Harry Howard et al. · European Journal of Pharmacology · 2001 · 288 citations
Psychoactive Drug, Psychiatry, Medicine +9
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
Renzo Mancuso, Gemma Fryatt, Madeleine Cleal et al. · Brain · 2019 · 224 citations · Full text
Immunology, Cell Death, Neurochemical Biomarkers +17
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
Jae Kyu Ryu, Victoria A. Rafalski, Anke Meyer‐Franke et al. · Nature Immunology · 2018 · 205 citations · Full text
Inflammation, Neurodegenerative Diseases, Medicine +8
1–5 of 32